|
|
Christian Vaisse, Karine Clement, Emmanuelle Durand, Serge Hercberg, Bernard Guy-Grand, Philippe Froguel
J Clin Invest. 2000;
106(2):253
doi:10.1172/JCI9238
Abstract |
Full text
| PDF

B
y integrating an agonist satiety signal, provided by alpha–melanocyte-stimulating hormone (α-MSH), and an antagonist signal, provided by agouti-related protein (AGRP), the melanocortin-4 receptor (MC4-R) is a key element in the hypothalamic control of food intake. Inactivation of the gene encoding this G protein–coupled receptor causes obesity in mice. In humans, frameshift mutations in MC4-R cause an early-onset dominant form of obesity in two families. In this study we find a high frequency (4%) of rare heterozygous MC4-R mutations in a large population of morbidly obese patients. No such mutations were found in controls. By analyzing the phenotypes of the probands carrying these mutations, we demonstrate that these patients display a common, nonsyndromic form of obesity. Interestingly, functional analysis of the mutant receptors indicates that obesity-associated defects in MC4-R range from loss of function to constitutive activation. Transmission of these mutations in the families of the carriers indicates a variable expressivity that is not related to the functional severity of the mutations. This variable expressivity of MC4-R–associated obesity is not due to variations in genes for α-MSH or AGRP. Taken together, these results demonstrate that MC4-R mutations are a frequent but heterogeneous genetic cause of morbid obesity.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Melanocortin 4 Receptor–Deficient Mice as a Novel Mouse Model of Non-Alcoholic Steatohepatitis
Michiko Itoh, Takayoshi Suganami, Nobutaka Nakagawa, Miyako Tanaka, Yukio Yamamoto, Yasutomi Kamei, Shuji Terai, Isao Sakaida, Yoshihiro Ogawa |
Amer J Pathol |
2011 |
.
|
Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations
Zhi-Qiang Wang, Ya-Xiong Tao |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease |
2011 |
.
|
The Obesogen Hypothesis: A Shift of Focus from the Periphery to the Hypothalamus
Stéphanie Decherf, Barbara A. Demeneix |
J of Toxicology & Env Hlth Part B |
2011 |
.
|
Segregation Analysis of Overweight Body Condition in an Experimental Cat Population
T. Haring, B. Wichert, G. Dolf, B. Haase |
J Hered |
2011 |
.
|
Melanocortin MC4 receptor expression sites and local function
Jacqueline E. Siljee-Wong |
EUROP J PHARMACOL |
2011 |
.
|
Physiological roles of the melanocortin MC3 receptor
Benjamin J. Renquist, Rachel N. Lippert, Julien A. Sebag, Kate L.J. Ellacott, Roger D. Cone |
EUROP J PHARMACOL |
2011 |
.
|
Programming towards Childhood Obesity
Patrick Tounian |
Ann Nutr Metab |
2011 |
.
|
The genetic epidemiology of melanocortin 4 receptor variants
Ruth J.F. Loos |
EUROP J PHARMACOL |
2011 |
.
|
Rescue of Melanocortin 4 Receptor (MC4R) Nonsense Mutations by Aminoglycoside-Mediated Read-Through
Harald Brumm, Jessica Mühlhaus, Florian Bolze, Susann Scherag, Anke Hinney, Johannes Hebebrand, Susanna Wiegand, Martin Klingenspor, Annette Grüters, Heiko Krude |
Obesity (Silver Spring Md) |
2011 |
.
|
Ciliary dysfunction and obesity
CA Mok, E Héon, M Zhen |
Clinical Genetics |
2010 |
.
|
Kenneth J. Valenzano, Elfrida R. Benjamin, Patricia René, Michel Bouvier |
GPCR Molecular Pharmacology and Drug Targeting |
2010 |
.
|
Regulation of lipid metabolism by energy availability: a role for the central nervous system
R. Nogueiras, M. López, C. Diéguez |
Obes Rev |
2010 |
.
|
Melanocortin-4 receptor gene variants in Chilean families: association with childhood obesity and eating behavior
M. Valladares, P. Domínguez-Vásquez, A.M. Obregón, G. Weisstaub, R. Burrows, A. Maiz, J.L. Santos |
Nutritional Neuroscience |
2010 |
.
|
Unconventional Wisdom About the Obesity Epidemic Symbol
Andrew R. Zinn |
Am J Med Science |
2010 |
.
|
γ2-Melanocyte stimulation hormone (γ2-MSH) truncation studies results in the cautionary note that γ2-MSH is not selective for the mouse MC3R over the mouse MC5R
Christine G. Joseph, Hua Yao, Joseph W. Scott, Nicholas B. Sorensen, Rebecca N. Marnane, Kathleen G. Mountjoy, Carrie Haskell-Luevano |
Peptides (Fayetteville) |
2010 |
.
|
From monogenic to polygenic obesity: recent advances
Anke Hinney, Carla I. G. Vogel, Johannes Hebebrand |
Eur Child Adolesc Psychiatry |
2010 |
.
|
Functions for pro-opiomelanocortin-derived peptides in obesity and diabetes
Kathleen G. Mountjoy |
Biochem J |
2010 |
.
|
Pregnancy and lactation have anti-obesity and anti-diabetic effects inAy/amice
E. N. Makarova, T. V. Yakovleva, A. Y. Shevchenko, N. M. Bazhan |
Acta Physiol |
2010 |
.
|
Melanocortin signaling in the CNS directly regulates circulating cholesterol
Diego Perez-Tilve, Susanna M Hofmann, Joshua Basford, Ruben Nogueiras, Paul T Pfluger, James T Patterson, Erin Grant, Hilary E Wilson-Perez, Norman A Granholm, Myrtha Arnold, James L Trevaskis, Andrew A Butler, William S Davidson, Stephen C Woods, Stephen C Benoit, Mark W Sleeman, Richard D DiMarchi, David Y Hui, Matthias H Tschöp |
Nature Neurosciences |
2010 |
.
|
Thyroid hormone exerts negative feedback on hypothalamic type 4 melanocortin receptor expression
S. Decherf, I. Seugnet, S. Kouidhi, A. Lopez-Juarez, M.-S. Clerget-Froidevaux, B. A. Demeneix |
Proc Natl Acad Sci U S A |
2010 |
.
|
|
|
|